by Annie De Groot | Jun 30, 2014 | Featured, Thinking Out Loud -Blog
Who: We’re so happy to see that the FDA included some of our favorite topics: Tregitope (as modulator of regulatory T cells), HLA (correlation with …) and analysis of HLA class II binding epitopes (presumably with silico tools, like our ISPRI toolkit) in...
by Annie De Groot | Jan 10, 2014 | Thinking Out Loud -Blog
New EpiVax Publication: “Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?” December 2013, Vol. 9, No. 12 , Pages 1155-1157 Anne S De Groot EpiVax, Inc., 146 Clifford St, Providence, RI 02903,...
by Annie De Groot | Dec 26, 2013 | Thinking Out Loud -Blog
Another great EpiVax article. Congratulations team! Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG? Anne S. De Groot,1,2 Leslie Cousens,2 Federico Mingozzi,3,4 and William Martin2 1Institute for Immunology and Informatics, University of Rhode Island,...
by Annie De Groot | Nov 18, 2013 | Events
EpiVax’ very own Dr. Annie De Groot is an invited speaker at the ASHI annual meeting this week. She will be providing a talk on the morning of Tuesday, November 19th, 2013 during the 39th annual meeting of American Society for Histocompatibility and...
by Annie De Groot | Nov 1, 2013 | Events
We are pleased to announce that EpiVax is hosting the “Tregitope Europe” meeting in conjunction with the 9th International Congress on Autoimmunity in Nice, France on March 26th 2014. The meeting will consist of a 120 minute scientific session as part of...
by Annie De Groot | Sep 25, 2013 | News
https://convergenceri.com/ EpiVax commits resources to bring its Tregitope platform to clinic A pioneering firm in immunogenicity comes of age PHOTO BY SCOTT KINGSLEY Dr. Anne S. De Groot, CEO of EpiVax, Inc., is one of the original biotech pioneers in Rhode Island....
by Annie De Groot | Jul 26, 2013 | News
A Brand New EpiVax Publication is Now Online! Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes (Tregitopes) Immune responses directed against viral capsid proteins constitute a main safety concern in the use of...
by Annie De Groot | Apr 24, 2013 | News
Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes Abstract HLA class II-restricted regulatory T cell (Treg) epitopes in IgG (also called “Tregitopes”) have been reported to...
by Annie De Groot | Mar 11, 2013 | Events
Tregtiope West was a great success! We would like to say ‘thank you’ to all of our speakers and to all those who attended. We had a wonderful turnout and your participation is very much appreciated. See below for a digital copy of the handouts and links to...
by Annie De Groot | Feb 12, 2013 | News
EpiVax-Novozymes Tregitope-Albumin Fusion Moves ‘Paradigm-Shifting’ Treatment for Diabetes Closer to Clinical Trials Full Article – https://bit.ly/EpiVaxNovoPR Providence, RI – EpiVax, Inc. is pleased to announce a new Collaborative Research Agreement with...
